top of page

EviMed

 

Matt WilliamsTony Hunter

 

EviMed uses argumentation to aggregate evidence from clinical trials

 

We have developed a series of techniques to allow us to combine evidence across a range of clinical outcome indicators, patient preferences and preferences over evidence.

 

We have published a range of technical papers where we have developed and expanded our work. We have now published a (clinical) systematic review of chemo-radiotherapy in lung cancer, where we show that our work offers similar outcomes to conventional approaches, but allows more information to be extracted from the trial data.

 

Resources available for download include papers, tables and images

bottom of page